These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31637814)

  • 21. Effects of combinations of gapmer antisense oligonucleotides on the target reduction.
    Yanagidaira M; Yoshioka K; Nagata T; Nakao S; Miyata K; Yokota T
    Mol Biol Rep; 2023 Apr; 50(4):3539-3546. PubMed ID: 36787053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.
    Yoshida T; Morihiro K; Naito Y; Mikami A; Kasahara Y; Inoue T; Obika S
    Nucleic Acids Res; 2022 Jul; 50(13):7224-7234. PubMed ID: 35801870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
    Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-
    Zhang L; Liang XH; De Hoyos CL; Migawa M; Nichols JG; Freestone G; Tian J; Seth PP; Crooke ST
    Nucleic Acid Ther; 2022 Oct; 32(5):401-411. PubMed ID: 35861704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.
    Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A
    Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway.
    Liang XH; Nichols JG; Hsu CW; Vickers TA; Crooke ST
    Nucleic Acids Res; 2019 Jul; 47(13):6900-6916. PubMed ID: 31165876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gapmer Antisense Oligonucleotides Targeting 5S Ribosomal RNA Can Reduce Mature 5S Ribosomal RNA by Two Mechanisms.
    Pollak AJ; Hickman JH; Liang XH; Crooke ST
    Nucleic Acid Ther; 2020 Oct; 30(5):312-324. PubMed ID: 32589504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy.
    Watt AT; Swayze G; Swayze EE; Freier SM
    Nucleic Acid Ther; 2020 Aug; 30(4):215-228. PubMed ID: 32125928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved targeting of miRNA with antisense oligonucleotides.
    Davis S; Lollo B; Freier S; Esau C
    Nucleic Acids Res; 2006; 34(8):2294-304. PubMed ID: 16690972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing the sequence-specificity of antisense oligonucleotides in drug discovery.
    Hagedorn PH; Hansen BR; Koch T; Lindow M
    Nucleic Acids Res; 2017 Mar; 45(5):2262-2282. PubMed ID: 28426096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity.
    Liang XH; Nichols JG; De Hoyos CL; Crooke ST
    Nucleic Acids Res; 2020 Sep; 48(17):9840-9858. PubMed ID: 32870273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides.
    Hori S; Yamamoto T; Obika S
    Biochem Biophys Res Commun; 2015 Aug; 464(2):506-11. PubMed ID: 26159921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the Prion Protein Binding Properties of Antisense Oligonucleotides.
    Reidenbach AG; Minikel EV; Zhao HT; Guzman SG; Leed AJ; Mesleh MF; Kordasiewicz HB; Schreiber SL; Vallabh SM
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides.
    Dieckmann A; Hagedorn PH; Burki Y; Brügmann C; Berrera M; Ebeling M; Singer T; Schuler F
    Mol Ther Nucleic Acids; 2018 Mar; 10():45-54. PubMed ID: 29499955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.
    Castanotto D; Lin M; Kowolik C; Wang L; Ren XQ; Soifer HS; Koch T; Hansen BR; Oerum H; Armstrong B; Wang Z; Bauer P; Rossi J; Stein CA
    Nucleic Acids Res; 2015 Oct; 43(19):9350-61. PubMed ID: 26433227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of Circular RNAs Using LNA-Modified Antisense Oligonucleotides.
    Løvendorf MB; Holm A; Petri A; Thrue CA; Uchida S; Venø MT; Kauppinen S
    Nucleic Acid Ther; 2023 Jan; 33(1):45-57. PubMed ID: 36445751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine-tuning of ENA gapmers as antisense oligonucleotides for sequence-specific inhibition.
    Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
    Oligonucleotides; 2007; 17(3):291-301. PubMed ID: 17854269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2-A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling.
    Kuespert S; Heydn R; Peters S; Wirkert E; Meyer AL; Siebörger M; Johannesen S; Aigner L; Bogdahn U; Bruun TH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
    Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP
    Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.